ArticleCell cycle (Georgetown, Tex.)2021

MicroRNA-30e-3p inhibits glioma development and promotes drug sensitivity to temozolomide treatment via targeting canopy FGF signaling regulator 2.

Ke Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.